bioRxiv ScienceSearch

bioRxiv · 10.1101/2021.01.06.425535

Independent Genomic Sources of Brain Structure and Function

Abstract

IntroductionThe last decade has seen a surge in well powered genome-wide association studies (GWASs) of complex behavioural traits, disorders, and more recently, of brain structural and functional neuroimaging features. However, the extreme polygenicity of these complex traits makes it difficult to translate the GWAS signal into mechanistic biological insights. We postulate that the covariance of SNP-effects across many brain features, as be captured by latent genomic components of SNP effect sizes. These may partly reflect the concerted multi-locus genomic effects through known molecular pathways and protein-protein interactions. Here, we test the feasibility of a new data-driven method to derive such latent components of genome-wide effects on more than thousand neuroimaging derived traits, and investigate their utility in interpreting the complex biological processes that shape the GWAS signal. MethodsWe downloaded the GWAS summary statistics of 3,143 brain imaging-derived phenotypes (IDPs) from the UK Biobank, provided by the Oxford Brain Imaging Genetics (BIG) Server (Elliott et al. 2018). Probabilistic independent component analysis (ICA) was used to extract two hundred independent genomic components from the matrix of SNP-effect sizes. We qualitatively describe the distribution of the latent components loadings in the neuroimaging and the genomic dimensions. Gene-wide statistics were calculated for each genomic component. We tested the genomic components enrichment for molecular pathways using MSigDB, and for single-cell RNA-sequencing of adult and foetal brain cells. Results200 components explained 80% of the variance in SNP-effects sizes. Each MRI modality and data processing method projected the imaging data into a clearly distinct cluster in the genomic component embedded space. Among the 200 genomic components, 157 were clearly driven by a single locus, while 39 were highly polygenic. Together, these 39 components were significantly enriched for 2,274 MSigDB gene sets (fully corrected for multiple testing across gene-sets and components). Several components were sensitive to molecular pathways, single cell expression profiles, and brain traits in patterns consistent with knowledge across these biological levels. To illustrate this, we highlight a component that implicated axonal regeneration pathways, which was specifically enriched for gene expression in oligodendrocyte precursors, microglia and astrocytes, and loaded highly on white matter neuroimaging traits. We highlight a second component that implicated synaptic function and neuron projection organization pathways that was specifically enriched for neuronal cell transcriptomes. ConclusionWe propose genomic ICA as a new method to identify latent genetic factors influencing brain structure and function by multimodal MRI. The derived latent genomic dimensions are highly sensitive to known molecular pathways and cell-specific gene expression profiles. Genomic ICA may help to disentangle the many different biological routes by which the genome defines the inter-individual variation of the brain. Future research is aimed at using this method to profile individual subjects genomic data along the new latent dimensions and evaluating the utility of these dimensions in stratifying heterogeneous patient populations.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Soheili-Nezhad, S., Beckmann, C. F., Sprooten, E.. 2021-01-07. Independent Genomic Sources of Brain Structure and Function. https://doi.org/10.1101/2021.01.06.425535

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience